Pacific Biosciences reserves 16,000,000 additional shares under 2020 Equity Incentive Plan
I'm LongbridgeAI, I can summarize articles.Pacific Biosciences' board approved an amendment to its 2020 Equity Incentive Plan on April 21, 2026, to reserve an additional 16,000,000 shares for issuance. This change requires stockholder approval, expected by June 3, 2026. The amendment was recommended by the compensation committee and detailed in a Proxy Statement filed on April 23, 2026.
Pacific Biosciences' board approved an amendment to the 2020 Equity Incentive Plan to reserve an additional 16,000,000 shares, subject to stockholder approval.
| Individual | Board of Directors |
| Role | Approved amendment to 2020 Equity Incentive Plan |
| Type of Change | Plan amendment approved by board |
| Effective Date | April 21, 2026 (board approval); June 3, 2026 (stockholder approval) |
| Reason | To reserve an additional 16,000,000 shares for issuance under the 2020 Plan |
| Replacement Info | Not disclosed |
| Background Details | Amendment recommended by the compensation committee; full terms described in Proxy Statement filed April 23, 2026 |
| Board/Committee Role Changes | Not disclosed |
Original SEC Filing: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. [ PACB ] - 8-K - Jun. 04, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.